Search Results - "Caroli, F."

Refine Results
  1. 1

    Novel spondyloepimetaphyseal dysplasia due to UFSP2 gene mutation by Di Rocco, M., Rusmini, M., Caroli, F., Madeo, A., Bertamino, M., Marre‐Brunenghi, G., Ceccherini, I.

    Published in Clinical genetics (01-03-2018)
    “…Beukes hip dysplasia is an autosomal dominant disease which has to date been described only in a large South African family of Dutch origin. The patients…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Does enhanced recovery improve the survival rates of patients 3 years after undergoing surgery to remove a tumor in the colon? by Viannay, P., Hamy, A., Jaouen, R., Caroli-Bosc, F. X., Luel, C., Vasseur, S., Levaillant, M., Hamel, J. F., Venara, Aurélien

    “…Purpose The advantages of enhanced recovery programs (ERP) after colorectal surgery for morbidity and length of stay are well known. On a longer term, evidence…”
    Get full text
    Journal Article
  4. 4

    Long‐term clinical profile of children with the low‐penetrance R92Q mutation of the TNFRSF1A gene by Pelagatti, M. A., Meini, A., Caorsi, R., Cattalini, M., Federici, S., Zulian, F., Calcagno, G., Tommasini, A., Bossi, G., Sormani, M. P., Caroli, F., Plebani, A., Ceccherini, I., Martini, A., Gattorno, M.

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-04-2011)
    “…Objective To analyze the long‐term impact of the R92Q mutation of TNFRSF1A in children with periodic fever, in comparison with children with tumor necrosis…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Epidermal growth factor receptor (EGFR) status in primary colorectal tumors correlates with EGFR expression in related metastatic sites: biological and clinical implications by Italiano, A., Saint-Paul, M.-C., Caroli-Bosc, F.-X., François, E., Bourgeon, A., Benchimol, D., Gugenheim, J., Michiels, J.-F.

    Published in Annals of oncology (01-09-2005)
    “…Background: Epidermal growth factor receptor (EGFR) plays an important role in the pathogenesis of colorectal cancer (CRC). There are several potential…”
    Get full text
    Journal Article
  7. 7

    Clinical and genetic characterization of Italian patients affected by CINCA syndrome by Caroli, F., Pontillo, A., D'Osualdo, A., Travan, L., Ceccherini, I., Crovella, S., Alessio, M., Stabile, A., Gattorno, M., Tommasini, A., Martini, A., Lepore, L.

    Published in Rheumatology (Oxford, England) (01-03-2007)
    “…Objective. We report the experience of the Italian Registry of patients affected by chronic infantile neurological, cutaneous, articular (CINCA) syndrome. The…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Major surface protein complex of Treponema denticola induces the production of tumor necrosis factor α, interleukin-1β, interleukin-6 and matrix metalloproteinase 9 by primary human peripheral blood monocytes by Gaibani, P., Caroli, F., Nucci, C., Sambri, V.

    Published in Journal of periodontal research (01-06-2010)
    “…Gaibani P, Caroli F, Nucci C, Sambri V. Major surface protein complex of Treponema denticola induces the production of tumor necrosis factor α, interleukin‐1β,…”
    Get full text
    Journal Article
  10. 10

    Human papillomavirus does not play a role in the Barrett esophagus: a French cohort by Brochard, C., Ducancelle, A., Pivert, A., Bodin, M., Ricard, A., Coron, E., Couffon, C., Dib, N., Luet, D., Musquer, N., Rhun, M. Le, Bertrais, S., Michalak, S., Lunel-Fabiani, F., Cesbron-Metivier, E., Bosc, F.-X. Caroli

    Published in Diseases of the esophagus (01-11-2017)
    “…Summary The role of human papillomavirus (HPV) in Barrett's esophagus (BE) has been examined but remains unclear. The purpose of the study is to dispute the…”
    Get full text
    Journal Article
  11. 11

    The combination of everolimus and zoledronic acid increase the efficacy of gemcitabine in a mouse model of pancreatic adenocarcinoma by Vitellius, Carole, Fizanne, Lionel, Menager-Tabourel, Elodie, Nader, Joelle, Baize, Nathalie, Laly, Margot, Lermite, Emilie, Bertrais, Sandrine, Caroli-Bosc, F X

    Published in Oncotarget (15-06-2018)
    “…Gemcitabine is a standard treatment for pancreatic adenocarcinoma. Many mechanisms are involved in gemcitabine resistance, such as reduced expression of the…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Endoscopic argon plasma trimming of biliary and gastrointestinal metallic stents by Vanbiervliet, G, Piche, T, Caroli-Bosc, F X, Dumas, R, Peten, E P, Huet, P M, Tran, A, Demarquay, J F

    Published in Endoscopy (01-05-2005)
    “…The aim of this study was to assess the feasibility and efficiency of plasma argon trimming of gastrointestinal and biliary metallic stents. A total of 31…”
    Get more information
    Journal Article
  14. 14

    Phase II study of paclitaxel combined with capecitabine as second-line treatment for advanced gastric carcinoma after failure of cisplatin-based regimens by Baize, N, Abakar-Mahamat, A, Mounier, N, Berthier, F, Caroli-Bosc, F. X

    Published in Cancer chemotherapy and pharmacology (01-07-2009)
    “…Purpose To determine the safety and the efficacy of paclitaxel and capecitabine as second-line combination chemotherapy after failure of platinum regimens in…”
    Get full text
    Journal Article
  15. 15

    Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study by Piche, T, Vanbiervliet, G, Cherikh, F, Antoun, Z, Huet, P M, Gelsi, E, Demarquay, J-F, Caroli-Bosc, F-X, Benzaken, S, Rigault, M-C, Renou, C, Rampal, P, Tran, A

    Published in Gut (01-08-2005)
    “…Background and aims: There are no available effective therapies for fatigue associated with chronic hepatitis C (CHC). The serotonin antagonist ondansetron has…”
    Get full text
    Journal Article
  16. 16

    GFAP mutations and polymorphisms in 13 unrelated Italian patients affected by Alexander disease by Caroli, F, Biancheri, R, Seri, M, Rossi, A, Pessagno, A, Bugiani, M, Corsolini, F, Savasta, S, Romano, S, Antonelli, C, Romano, A, Pareyson, D, Gambero, P, Uziel, G, Ravazzolo, R, Ceccherini, I, Filocamo, M

    Published in Clinical genetics (01-11-2007)
    “…Alexander disease (AD), a rare neurodegenerative disorder of the central nervous system, is characterized by the accumulation of cytoplasmic protein aggregates…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Persons suffering from schizophrenia and relapses by Passerieux, C, Caroli, F, Giraud-Baro, E

    Published in Encéphale (01-12-2009)
    “…In schizophrenia, relapse is a common event that affects more than half the patients within 2 years after a first episode. It is a real setback for them and…”
    Get more information
    Journal Article
  19. 19

    High-dose, single-agent irinotecan as first-line therapy in the treatment of metastatic colorectal cancer by YCHOU, M, RAOUL, J. L, COUTEAU, C, MERROUCHE, Y, DESSEIGNE, F, BOREL, C, CAROLI-BOSC, F. X, JACOB, J. H, SEITZ, J. F, KRAMAR, A, HUA, A, LEFEBVRE, P

    Published in Cancer chemotherapy and pharmacology (01-11-2002)
    “…The efficacy and safety of single-agent, high-dose irinotecan (CPT-11, Campto) 500 mg/m(2) every 3 weeks were investigated as first-line treatment for advanced…”
    Get full text
    Journal Article
  20. 20